Cue
Chris Achar has served as a member of the board of directors since May 2018 and was appointed as the Chief Strategy Officer in June 2021. Chris is the founder of Genzum Life Sciences, Inc., a pharmaceutical company, and has served as its chief executive officer since 2010. Prior, Chris founded Synergy Ventures, a venture capital company where he serves as a general partner, whose investments include seed-stage funding to several medical technology companies including Cue BioPharma Inc. and Provention Bio Inc.
Chris has served as a member of the board of directors of the Network for Teaching Entrepreneurship since 2018. Chris holds a B.S. in business marketing from California State University and an M.B.A. from Pepperdine University School of Business.
This person is not in any offices
Cue
1 followers
Cue is on a mission is to create tools that empower physicians and consumers by increasing their access to actionable data. They are developing advanced technology and manufacturing to solve significant and important problems in healthcare. Headquartered in the Sorrento Valley area of San Diego, California, Cue is composed of multi-disciplinary engineering, regulatory, clinical, operations, production, and testing teams.